Atorvastatin efficiency after traumatic brain injury in rats

Surgical Neurology

Volumn 72, Issue 2, 2009, Pages 146-152

  Turkoglu, Omer Faruk ^a   Eroglu, Hakan ^b   Okutan, Ozerk ^a   Gurcan, Oktay ^c   Bodur, Ebru ^b   Sargon, Mustafa F ^b   Öner, Levent ^b   Beskonakli, Etem ^a  

^a ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

^c Ankara Numune Research and Education Hospital   (Turkey)

Author keywords

Atorvastatin; Brain edema; Lipid peroxidation; Traumatic brain injury

Indexed keywords

ATORVASTATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN EDEMA; CONTROLLED STUDY; CRANIECTOMY; DRUG EFFICACY; LIPID PEROXIDATION; NEUROPROTECTION; NONHUMAN; RAT; TRANSMISSION ELECTRON MICROSCOPY; TRAUMATIC BRAIN INJURY;

ANALYSIS OF VARIANCE; ANIMALS; BRAIN; BRAIN EDEMA; BRAIN INJURIES; CEREBROVASCULAR CIRCULATION; CRANIOTOMY; DISEASE MODELS, ANIMAL; HEPTANOIC ACIDS; LIPID PEROXIDATION; MALE; MICROCIRCULATION; MICROSCOPY, ELECTRON, TRANSMISSION; NEUROPROTECTIVE AGENTS; ORGAN SIZE; PYRROLES; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 67650086674     PISSN: 00903019     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surneu.2008.07.004     Document Type: Article

References (39)

1. Beckman J.S., Beckman T.W., Chen J., et al. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A 87 (1990) 1620-1624
2. Blanco M., Nombela F., Castellanos M., Rodriguez-Yanez M., et al. Statin treatment withdrawal in ischemic stroke: a controlled randomized study. Neurology 69 (2007) 904-910
3. Bosel J., Gandor F., Harms C., et al. Neuroprotective effects of atorvastatin against glutamate-induced excitotoxicity in primary cortical neurons. J Neurochem 92 (2005) 1386-1398
4. Braughler J.M., and Hall E.D. Central nervous system trauma and stroke. I. Biochemical considerations for oxygen radical formation and lipid peroxidation. Free Radic Biol Med 6 (1989) 289-301
5. Bullock R., Butcher S.P., Chen M.H., et al. Correlation of the extracellular glutamate concentration with extent of blood flow reduction after subdural hematoma in the rat. J Neurosurg 74 (1991) 794-802
6. Bullock R., Zauner A., Woodward J.J., et al. Factors affecting excitatory amino acid release following severe human head injury. J Neurosurg 89 (1998) 507-518
7. Burney S., Caulfield J.L., Niles J.C., et al. The chemistry of DNA damage from nitric oxide and peroxynitrite. Mutat Res 424 (1999) 37-49
8. Buttmann M., Lorenz A., Weishaupt A., et al. Atorvastatin partially prevents an inflammatory barrier breakdown of cultured human brain endothelial cells at a pharmacologically relevant concentration. J Neurochem 102 (2007) 1001-1008
9. Chen S.F., Hung T.H., Chen C.C., et al. Lovastatin improves histological and functional outcomes and reduces inflammation after experimental traumatic brain injury. Life Sci 81 (2007) 288-298
10. Cottrell J.R., Dube G.R., Egles C., et al. Distribution, density, and clustering of functional glutamate receptors before and after synaptogenesis in hippocampal neurons. J Neurophysiol 84 (2000) 1573-1587
11. Eroglu H., Kas H.S., Oner L., et al. The in-vitro and in-vivo characterization of PLGA:L-PLA microspheres containing dexamethasone sodium phosphate. J Microencapsul 18 (2001) 603-612
12. Faden A.I., Demediuk P., Panter S.S., et al. The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science 244 (1989) 798-800
13. Feeney D.M., Boyeson M.G., Linn R.T., et al. Responses to cortical injury: I. Methodology and local effects of contusions in the rat. Brain Res 211 (1981) 67-77
14. Halliwell B., and Gutteridge J.M.C. Oxygen radicals and the nervous-system. Trends Neurosci 8 (1985) 22-26
15. Hayashi T., Hamakawa K., Nagotani S., et al. HMG CoA reductase inhibitors reduce ischemic brain injury of Wistar rats through decreasing oxidative stress on neurons. Brain Res 1037 (2005) 52-58
16. Hong H., Zeng J.S., Kreulen D.L., et al. Atorvastatin protects against cerebral infarction via inhibition of NADPH oxidase-derived superoxide in ischemic stroke. Am J Physiol Heart Circ Physiol 291 (2006) H2210-H2215
17. Jick H., Zornberg G.L., Jick S.S., et al. Statins and the risk of dementia. Lancet 356 (2000) 1627-1631
18. Kuipers H.F., and van den Elsen P.J. Immunomodulation by statins: inhibition of cholesterol vs. isoprenoid biosynthesis. Biomed Pharmacother 61 (2007) 400-407
19. Laufs U., Gertz K., Huang P., et al. Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice. Stroke 31 (2000) 2442-2449
20. Leffler C.W., Busija D.W., Armstead W.M., et al. Activated oxygen and arachidonate effects on newborn cerebral arterioles. Am J Physiol 259 (1990) H1230-H1238
21. Lenzlinger P.M., Morganti-Kossman M.C., Laurer H.L., et al. The duality of the inflammatory response to traumatic brain injury. Mol Neurobiol 24 (2001) 169-181
22. Lipton S.A. Pathologically-activated therapeutics for neuroprotection: mechanism of NMDA receptor block by memantine and S-nitrosylation. Curr Drug Targets 8 5 (2007) 621-632
23. Lu D., Goussev A., Chen J., et al. Atorvastatin reduces neurological deficit and increases synaptogenesis, angiogenesis, and neuronal survival in rats subjected to traumatic brain injury. J Neurotrauma 21 (2004) 21-32
24. Maxwell R.E., Long D.M., and French L.A. The effects of glucosteroids on experimental cold-induced brain edema. Gross morphological alterations and vascular permeability changes. J Neurosurg 34 (1971) 477-487
25. Murakami K., Kondo T., Yang G., et al. Cold injury in mice: a model to study mechanisms of brain edema and neuronal apoptosis. Prog Neurobiol 57 (1999) 289-299
26. Ozdemir D., Uysal N., Gonenc S., et al. Effect of melatonin on brain oxidative damage induced by traumatic brain injury in immature rats. Physiol Res 54 (2005) 631-637
27. Ray S.K., Dixon C.E., and Banik N.L. Molecular mechanisms in the pathogenesis of traumatic brain injury. Histol Histopathol 17 (2002) 1137-1152
28. Riad A., Du J., Stiehl S., et al. Low-dose treatment with atorvastatin leads to anti-oxidative and anti-inflammatory effects in diabetes mellitus. Eur J Pharmacol 569 (2007) 204-211
29. Rice A.C., Khaldi A., Harvey H.B., et al. Proliferation and neuronal differation of mitotically active cells following traumatic brain injury. Exp Neurol 183 (2003) 406-417
30. Seyfried D., Han Y., Lu D., et al. Improvement in neurological outcome after administration of atorvastatin following experimental intracerebral hemorrhage in rats. J Neurosurg 101 (2004) 104-107
31. Sparks D.L., Connor D.J., Browne P.J., et al. HMG-CoA reductase inhibitors (statins) in the treatment of Alzheimer's disease and why it would be ill-advise to use one that crosses the blood-brain barrier. J Nutr Health Aging 6 (2002) 324-331
32. Tsubokawa T., Jadhav V., Solaroglu I., et al. Lecithinized superoxide dismutase improves outcomes and attenuates focal cerebral ischemic injury via antiapoptotic mechanisms in rats. Stroke 38 (2007) 1057-1062
33. Turkoglu O.F., Eroglu H., Okutan O., Bodur E., Sargon M.F., Ozer N., Oner L., and Beskonakli E. A comparative study for the evaluation of brain edema: Magnesium sulphate vs. dexamethasone sodium phosphate. J Clin Neurosci 15 (2008) 60-65
34. Vaughan C.J., and Delanty N. Neuroprotective properties of statins in cerebral ischemia and stroke. Stroke 30 (1990) 1969-1973
35. Wang H., Lynch J.R., Song P., et al. Simvastatin and atorvastatin improve behavioral outcome, reduce hippocampal degeneration, and improve cerebral blood flow after experimental traumatic brain injury. Exp Neurol 206 (2007) 59-69
36. Wei E.P., Ellison M.D., Kontos H.A., et al. O-2 radicals in arachidonate-induced increased blood-brain-barrier permeability to proteins. Am J Physiol 251 (1986) H693-H699
37. Willerson J.T., and Ridker P.M. Inflammation as a cardiovascular risk factor. Circulation 109 (2004) 2-10
38. Youssef S., Stuve O., Patarroyo J.C., et al. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature 420 (2002) 78-84
39. Zacco A., Togo J., Spence K., et al. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors protect cortical neurons from excitotoxicity. J Neurosci 23 (2003) 11104-11111